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One sentence summary: This study shows that clinical isolates of Pseudomonas aeruginosa can induce in parallel cytotoxicity and modulation of cytokine
balance in the host cells, depending on the virulence factors they produce.
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ABSTRACT
Type III secretion system (T3SS) in Pseudomonas aeruginosa is associated with poor clinical outcome in acute infections. T3SS
allows for injection of bacterial exotoxins (e.g. ExoU or ExoS) into the host cell, causing cytotoxicity. It also activates the
cytosolic NLRC4 inflammasome, activating caspase-1, inducing cytotoxicity and release of mature IL-1β, which impairs
bacterial clearance. In addition, flagellum-mediated motility has been suggested to also modulate inflammasome response
and IL-1β release. Yet the capacity of clinical isolates to induce IL-1β release and its relation with cytotoxicity have never
been investigated. Using 20 clinical isolates from acute infections with variable T3SS expression levels and human
monocytes, our aim was to correlate IL-1β release with toxin expression, flagellar motility and cytotoxicity. ExoU-producing
isolates caused massive cell death but minimal release of IL-1β, while those expressing T3SS but not ExoU (i.e. expressing
ExoS or no toxins) induced caspase-1 activation and IL-1β release, the level of which was correlated with cytotoxicity. Both
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effects were prevented by a specific caspase-1 inhibitor. Flagellar motility was not correlated with cytotoxicity or IL-1β
release. No apoptosis was detected. Thus, T3SS cytotoxicity is accompanied by a modification in cytokine balance for
P. aeruginosa clinical isolates that do not express ExoU.
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Pseudomonas aeruginosa is a major cause of healthcare-
associated infections, with severe morbidity and high mortality.
Its capacity to develop antibiotic resistance limits therapeutic
options, leading to treatment failures.Moreover, the P. aeruginosa
genome encodes several virulence factors and environmen-
tal sensor-regulator systems, allowing it to adapt to hostile
environments, induce tissue injury and control inflammatory
reactions. Studying cellular responses to the virulence factors
expressed by clinical isolates is critical in order to evaluate the
usefulness of combining antibiotics with specific inhibitors of
these virulence mechanisms or immunomodulators.
Type III secretion system (T3SS) is a major virulence factor
in P. aeruginosa, associated with poor clinical outcome and high
morbidity in acute infections. T3SS enables bacteria to inject ex-
otoxins into the host cell cytoplasm (Sawa 2014). Among them,
the phospholipase A2 ExoU causes rapid cell death by disrupting
membrane integrity, while ExoS prevents bacterial internaliza-
tion and induces cell necrosis or apoptosis (Okuda, Hanabusa
and Gotoh 2014). Beside these toxin-dependent effects, T3SS
also delivers flagellin or T3SS rod proteins into the mammalian
cytosol, inducing secretion of IL-1β and IL-18 (Miao et al. 2008,
2010). Contrary to TNF-α, IL-1β and IL-18 secretion requires two
signals (Miao et al. 2008), namely (i) Toll-like receptor (TLR) ac-
tivation (inducing transcription and translation of the proforms
of these cytokines) and (ii) NOD-like receptors (NLR) (activating
caspase-1 and inducing cytokine processing and secretion, lead-
ing to pyroptotic cell death). Pseudomonas aeruginosa T3SS specif-
ically activates NLRC4 (NLR family, CARD domain containing 4;
also known as Ipaf) inflammasome. In the case of P. aeruginosa
infection, IL-1β release seems essentially related to this process,
as it is totally inhibited in nlrc4 -/-macrophages (Faure et al. 2014).
Bacteria-induced inflammasome activation and subsequent
IL-1β and IL-18 release have been generally considered as pro-
tective (Sutterwala et al. 2007; Cai et al. 2012). Yet, in the case
of P. aeruginosa infections, these processes are rather deleteri-
ous, contributing to increased tissue injury and impaired bacte-
rial clearance (Schultz et al. 2002; Cohen and Prince 2013; Faure
et al. 2014). Moreover, flagellum–mediatedmotility has been sug-
gested to also modulate inflammasome response and IL-1β re-
lease (Patankar et al. 2013). At this stage, however, these con-
cepts have been studied onlywith reference strains andmutants
thereof expressing or not specific proteins from the T3SS or the
flagellum.
In this context, this study aimed at (i) examining whether
T3SS positive-clinical isolates collected from patients suffering
from acute infections are also able to induce IL-1β release and
(ii) determining whether the IL-1β production is related to toxin
expression or flagellarmotility, and correlates with the degree of
cytotoxicity induced. TNF-α release was also followed as a con-
trol because its production is unrelated to inflammasome acti-
vation (Akira and Takeda 2004). Human THP-1 monocytes were
used as model of phagocytic cells capable to activate NLRC4 in-
flammasome in response to T3SS.
Table S1 (Supporting Information) shows the strains un-
der study. They include (i) 20 clinical isolates from acute
infections retrospectively collected in four Belgian hospi-
tals, (ii) three reference strains, namely PA103 (expressing
ExoU), PAO1 and CHA (expressing ExoS, ExoT, ExoY) and
(iii) mutants with deletions in genes coding for T3SS tox-
ins (PA103UT; CHASTY), proteins from the translocation
apparatus (PA103pcrV; CHApopB/popD) or T3SS regulon
(CHAExsA). These strains were characterized for the expres-
sion of genes encoding toxins, translocation apparatus or flag-
ellin, and for swarming motility in 0.3% LB agar plate. Their
serotype and genetic relatedness were determined in order to
check for sufficient diversity within the collection (Table S1 and
Fig. S1, Supporting Information).
If excluding negative controls (PA103pcrV, CHApopBD,
CHAExsA), the other strains could be classified in two groups
(Table S1, Supporting Information), namely (i) 8 clinical isolates
plus PA103 expressing ExoU, ExoT and the translocation appa-
ratus (T3SS+ ExoU+) and (ii) 12 clinical isolates plus PAO1, CHA,
CHASTY and PA103UT expressing the translocation appara-
tus but not the ExoU toxin (T3SS+ExoU−). ExoS+ strains were
thus more represented in this collection than ExoU+ strains,
and none of them expressed both toxins, as generally observed
(Garey et al. 2008; El-Solh et al. 2012). No toxin was expressed in
PA103UT and CHASTY. exoU, exoS and exoT expression levels
were highly variable, ranging from 283 to 1% of the values mea-
sured in reference strains. Flagellin expression and swimming
motility were variable, with no correlation between flagellin ex-
pression and motility (Table S2, Supporting Information).
THP-1 monocytes were then incubated with each of these
isolates. Cytotoxicity was assessed by measuring lactate dehy-
drogenase (LDH) release in the culture supernatant. IL-1β and
TNF-α were quantified in supernatants by ELISA. As IL-1β is
released in response to caspase-1 activation, cells were also
preincubated with 40 μM of the specific caspase-1 inhibitor Ac-
YVAD-cmk (N-acetyl-tyrosyl-valyl-alanyl-aspartyl chloromethyl
ketone, Sigma-Aldrich, Saint-Louis, MO). Incubation time was
set at 5 h based on preliminary experiments demonstrating that
cytotoxicity was essentially mediated by T3SS in these condi-
tions (see values in Fig. 1; cytotoxicity high for PA103; moderate
for CHA and largest difference with that of CHAExsA).
Figure 1 shows data for each individual strain (left) or for
T3SS+ strains grouped according to the expression of ExoU
(right). Considering reference strains, PA103 induced a massive
LDH release but a low release of cytokines, which was not af-
fected by Ac-YVAD-cmk. CHA was less cytotoxic but induced
a significantly larger release of IL-1β (reversed by Ac-YVAD-
cmk) but not of TNF-α. Remarkably, PA103UT and CHASTY
showed a profile similar to that of CHA despite the fact they
did not express any toxin but still the translocation appara-
tus. PA103pcrV, CHApopBD and CHAExsA were not cyto-
toxic and inducedminimal IL-1β release. All together, these data
confirm the role of T3SS apparatus rather than toxins in this
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Figure 1. Cytotoxicity and cytokine production induced by P. aeruginosa reference strains and clinical isolates. THP-1 cells seeded into 96-well plates (2.5 × 105 cells/mL)
were incubated with each of these isolates (10 bacteria/cell) during 5 h. Cytotoxicity was assessed by measuring the release of LDH into the culture supernatant using
the cytotoxicity detection kit PLUS (Roche, Basel, Switzerland). IL-1β and TNF-α were quantified in supernatants using a commercially available ELISA kit (R&D systems,
Minneapolis, MN and BD Biosciences, San Jose, CA, respectively). Upper panels: percentage of release of LDH (A and B), IL-1β (C and D) and TNF-α (E and F) in the
supernatant of THP-1monocytes exposed during 5 h to clinical isolates (10 bacteria/cell) in the presence of the caspase-1 inhibitor Ac-YVAD-cmk [+YVAD] or in control
conditions [−YVAD; DMSO added as the solvent of Ac-YVAD-cmk]. Left panels show the data for individual strains, and right panels for strains grouped according
to the expression of ExoU toxin. Values are mean ± SD of representative experiments performed in triplicates and reproduced at three independent occasions at
least with similar results. Statistical analyses performed among groups of strains using two-way ANOVA, Bonferroni post-test: ∗∗∗ P < 0.001, ∗ P < 0.05. Lower panels:
correlation between IL-1β and TNF-α release (G), IL-1β and LDH release (H), and TNF-α and LDH release (I) for all strains in control conditions (G) or for strains grouped
according to the production of ExoU toxin (H and I) (r2 = coefficient of determination; rp = Pearson correlation coefficient).
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process (Miao et al. 2008). PA103UT and CHASTY induced a
larger IL-1β release than their parental strains, which is com-
patible with the previously demonstrated inhibitory effect of the
toxins on inflammasome activation (Sutterwala et al. 2007; Galle
et al. 2008). Moving to clinical isolates, all T3SS+ExoU+ isolates
behaved as PA103, while all T3SS+ExoU− isolates caused only
20–50% LDH release and a commensurate release of IL-1β but not
of TNF-α. Again Ac-YVAD-cmk significantly reduced cytotoxicity
and IL-1β release for T3SS+ExoU− isolates, with no influence on
TNF-α release. Inflammasome activation by T3SS+ ExoU− iso-
lates was confirmed in western blot by the presence of the ac-
tive form of caspase-1 and of IL-1β in cell culture supernatants,
which was not observed for T3SS+ExoU+ isolates (Fig. S2, Sup-
porting Information). As the latter isolates were more cytotoxic,
we also checked that inflammasome activation did not occur
earlier. To this effect, we followed LDH and IL-1β release over
time and showed that they were never inhibited by Ac-YVAD-
cmk (Fig. S3, Supporting Information).
In parallel, we looked for the presence of apoptotic cells vs
necrotic cells over 5 h of incubation using representative ExoU+
or ExoU− strains and found that cell death was associated with
membrane permeabilization (necrosis or pyroptosis) but not
apoptosis whatever the incubation time (Fig. S4, Supporting In-
formation), as previously demonstrated for CHA (Dacheux et al.
2000).
Potential relationships between toxin or flagellin expression,
motility and cytotoxicity or cytokine release were systemati-
cally looked for by appropriate statistical analysis of the corre-
lations between pairs of parameters (Table S2, Supporting Infor-
mation). Globally, a highly significant correlation was observed
between IL-1β and TNF-α secretion in the absence of Ac-YVAD-
cmk (Fig. 1G). Moreover, the release of IL-1β but not that of TNF-α
was correlated with cytotoxicity, whether cells were pretreated
or not with Ac-YVAD-cmk, but only for T3SS+ExoU– strains
(Fig. 1H/I). Other correlations were not significant.
The main conclusion from this study is that cytotoxicity ex-
erted by T3SS-positive clinical isolates from acute infections
is correlated with IL-1β release for strains that do not express
ExoU. The high cytotoxicity of T3SS+ExoU+ isolates could rely
on the phospholipase activity of the toxin, whichmay cause cell
lysis before any mechanism of cell response could be activated
(Sato and Frank 2004). Low IL-1β levels detected after 5 h incu-
bation correspond to its proform released in the medium after
cell death, which explains why Ac-YVAD-cmk did not prevent
this process. Conversely, cytotoxicity and IL-1β release induced
by T3SS+ExoU− strains are largely inhibited by Ac-YVAD-cmk,
being consecutive to caspase-1 activation (probably related to
NLRC4 inflammasome). Notably also, we did not observe an in-
verse correlation between toxin expression levels and IL-1β se-
cretion, in spite of the described inhibitory effect of the toxin
on inflammasome activation (Sutterwala et al. 2007; Galle et al.
2008).
We also noticed a correlation between TNF-α and IL-1β re-
lease induced by the whole collection. This probably results
from a simultaneous production of TNF-α and proIL-1β via TLR
activation, because the correlation is lost in the presence of
Ac-YVAD-cmk that prevents proIL-1β maturation. We can nei-
ther exclude a cytotoxicity related to indirect caspase-1 acti-
vation via caspase-11 activation in response to LPS (Kayagaki
et al. 2013).
On the contrary, we were unable to demonstrate any corre-
lation between flagellin expression level (Miao et al. 2008; Cohen
and Prince 2013) and flagellar motility (Patankar et al. 2013) or
between motility and cytotoxicity or cytokine release.
Secretion of ExoU is considered as a marker of high viru-
lence (Schulert et al. 2003), but expression of ExoU or ExoS has
been both associated with poor clinical outcome (El-Solh et al.
2012). We show here that the pattern of cytokines expressed by
the host cells in response to T3SS depends, at least in vitro, on
whether the strain expresses or not ExoU.
Thus, pending for animal studies aiming at confirming these
observations and further exploring the consequences of this cy-
tokine dysbalance, our data suggest that inhibiting T3SS func-
tionality by immunotherapy or small compounds (Kline et al.
2012) may be more appropriate than blocking specifically tox-
ins. This work opens the door to the study of innovative ther-
apeutic strategy to be combined with antibiotics during acute
pseudomonal infections.
SUPPLEMENTARY DATA
Supplementary data are available at FEMSPD online.
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